Concepedia

Chao Zhu

CZ

Statistics

Publications

28

Citations

3.2K

H-Index

17

Active since

2007

Affiliations

Bristol-Myers Squibb (United States)(Current)

First Affiliated Hospital of Anhui Medical University

Anhui Medical University

The University of Texas MD Anderson Cancer Center

University of Bologna

Chao Zhu is an author at Bristol-Myers Squibb (United States) specializing in medicine, health sciences, and radiation oncology.

ORCID

Top concepts

Publications per year

2007–2023

28

Publications

28

Dasatinib versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia

Hagop M. Kantarjian, Neil P. Shah, Andreas Hochhaus et al. · New England Journal of Medicine · 2010 · 1.6K citations

Dasatinib or imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: 2-year follow-up from a randomized phase 3 trial (DASISION)

Hagop M. Kantarjian, Neil P. Shah, Jörge E. Cortes et al. · Blood · 2011 · 601 citations · Full text

Efficacy and safety of dasatinib in imatinib-resistant or -intolerant patients with chronic myeloid leukemia in blast phase

Jörge E. Cortes, D-W Kim, Emmanuel Raffoux et al. · Leukemia · 2008 · 198 citations

, , +6

Phase 3 study of dasatinib 140 mg once daily versus 70 mg twice daily in patients with chronic myeloid leukemia in accelerated phase resistant or intolerant to imatinib: 15-month median follow-up

Hagop M. Kantarjian, Jörge E. Cortes, Dong‐Wook Kim et al. · Blood · 2009 · 170 citations · Full text

Dasatinib in imatinib‐resistant or imatinib‐intolerant chronic myeloid leukemia in blast phase after 2 years of follow‐up in a phase 3 study

Giuseppe Saglio, Andreas Hochhaus, Yeow Tee Goh et al. · Cancer · 2010 · 124 citations

1–5 of 28